BioLineRx (BLRX) Tops Q2 EPS by 7c
Get Alerts BLRX Hot Sheet
Join SI Premium – FREE
BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.02), $0.07 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Similarweb Ltd. (SMWB) Tops Q2 EPS by 3c
- WhiteFiber, Inc. (WYFI) Misses Q2 EPS by 36c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share